|
2010 Journal Article Meropenem: Focus on its use in serious bacterial infectionsRoberts, Jason A., Ulldemolins, Marta and Lipman, Jeffrey (2010). Meropenem: Focus on its use in serious bacterial infections. Clinical Medicine Reviews in Therapeutics, 2, 1-14. doi: 10.4137/CMRT.S4598 |
|
2010 Journal Article Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?Roberts, Jason A., Hope, William W. and Lipman, Jeffrey (2010). Therapeutic drug monitoring of beta-lactams for critically ill patients: Unwarranted or essential?. International Journal of Antimicrobial Agents, 35 (5), 419-420. doi: 10.1016/j.ijantimicag.2010.01.022 |
|
2010 Journal Article Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsMartin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24. |
|
2010 Journal Article First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsisRoberts, Jason A., Kirkpatrick, Carl M. J., Roberts, Michael S., Dalley, Andrew J. and Lipman, Jeffrey (2010). First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. International Journal of Antimicrobial Agents, 35 (2), 156-163. doi: 10.1016/j.ijantimicag.2009.10.008 |
|
2010 Journal Article Augmented renal clearance: Implications for antibacterial dosing in the critically IllUdy, Andrew A., Roberts, Jason A., Boots, Robert J., Paterson, David L. and Lipman, Jeffrey (2010). Augmented renal clearance: Implications for antibacterial dosing in the critically Ill. Clinical Pharmacokinetics, 49 (1), 1-16. doi: 10.2165/11318140-000000000-00000 |
|
2009 Journal Article Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) studyRanganathan, Dwarakanathan, Varghese, Julie M., Fassett, Robert G., Lipman, Jeffrey, D'Intini, Vincent, Healy, Helen and Roberts, Jason A. (2009). Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study. BMC Nephrology, 10 (1) 42, 1-6. doi: 10.1186/1471-2369-10-42 |
|
2009 Journal Article Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasisRoberts, Jason A., Udy, Andrew A., O'Donoghue, Stephen, Briscoe, Scott, Paterson, David L. and Lipman, Jeffrey (2009). Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis. International Journal of Antimicrobial Agents, 34 (4), 383-384. doi: 10.1016/j.ijantimicag.2009.05.005 |
|
2009 Journal Article Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus DosingRoberts, JA and Lipman, J (2009). Tissue Distribution of Beta-Lactam Antibiotics: Continuous versus Bolus Dosing. Journal of Pharmacy Practice and Research, 39 (3), 219-222. doi: 10.1002/j.2055-2335.2009.tb00457.x |
|
2009 Journal Article Midazolam metabolism: Implications for individualised dosing?Roberts, Jason A., Coulthard, Mark G., Addison, Russell S., Foot, Carole and Lipman, Jeffrey (2009). Midazolam metabolism: Implications for individualised dosing?. Journal of Pharmacy Practice and Research, 39 (3), 198-201. doi: 10.1002/j.2055-2335.2009.tb00452.x |
|
2009 Journal Article Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapyRoberts, Jason A. and Lipman, Jeffrey (2009). Dose matters: Dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy. Critical Care Medicine, 37 (8), 2491-2492. doi: 10.1097/CCM.0b013e3181aee840 |
|
2009 Journal Article A systematic review on clinical benefits of continuous administration of [beta]-lactam antibioticsRoberts, Jason A., Webb, Steven, Paterson, David, Ho, Kwok M. and Lipman, Jeffrey (2009). A systematic review on clinical benefits of continuous administration of [beta]-lactam antibiotics. Critical Care Medicine, 37 (6), 2071-2078. doi: 10.1097/CCM.0b013e3181a0054d |
|
2009 Journal Article Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?Roberts, Jason A., Roberts, Michael S., Robertson, Thomas A., Dalley, Andrew J. and Lipman, Jeffrey (2009). Piperacillin penetration into tissue of critically ill patients with sepsis - Bolus versus continuous administration?. Critical Care Medicine, 37 (3), 926-933. doi: 10.1097/CCM.0b013e3181968e44 |
|
2009 Journal Article Pharmacokinetic issues for antibiotics in the critically ill patientRoberts, Jason A. and Lipman, Jeffrey (2009). Pharmacokinetic issues for antibiotics in the critically ill patient. Critical Care Medicine, 37 (3), 840-851. doi: 10.1097/CCM.0b013e3181961bff |
|
2009 Journal Article Effective dose from cone beam CT examinations in dentistryRoberts, J. A., Drage, N. A., Davies, J. and Thomas, D. W. (2009). Effective dose from cone beam CT examinations in dentistry. British Journal of Radiology, 82 (973), 35-40. doi: 10.1259/bjr/31419627 |
|
2009 Journal Article Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distributionRoberts, Jason A., Kirkpatrick, Carl M. J., Roberts, Michael S., Robertson, Thomas A., Dalley, Andrew J. and Lipman, Jeffrey (2009). Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. Journal of Antimicrobial Chemotherapy, 64 (1), 142-150. doi: 10.1093/jac/dkp139 |
|
2009 Journal Article You only find what you look for: The importance of high creatinine clearance in the critically illUdy, A., Roberts, J. A., Boots, R. J. and Lipman, J. (2009). You only find what you look for: The importance of high creatinine clearance in the critically ill. Anaesthesia and Intensive Care, 37 (1), 11-13. doi: 10.1177/0310057x0903700123 |
|
2008 Journal Article Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?Roberts, Jason A, Lipman, Jeffrey, Blot, Stijn and Rello, Jordi (2008). Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Current Opinion in Critical Care, 14 (4), 390-396. doi: 10.1097/MCC.0b013e3283021b3a |
|
2008 Journal Article Antibiotic resistance - what's dosing got to do with it?Roberts, Jason A., Kruger, Peter, Paterson, David L. and Lipman, Jeffrey (2008). Antibiotic resistance - what's dosing got to do with it?. Critical Care Medicine, 36 (8), 2433-2440. doi: 10.1097/CCM.0b013e318180fe62 |
|
2008 Journal Article Lessons learnt in the pharmacokinetic analysis of the effect of haemoperfusion for acute overdose with sustained-release diltiazemD. M. Roberts, J. A. Roberts, R. J. Boots, R. Mason and J. Lipman (2008). Lessons learnt in the pharmacokinetic analysis of the effect of haemoperfusion for acute overdose with sustained-release diltiazem. Anaesthesia, 63 (7), 714-718. doi: 10.1111/j.1365-2044.2008.05477.x |
|
2008 Journal Article Continuous infusion of time-dependent antibiotics: lung pharmacokinetics and pharmacodynamicsRoberts, Jason A., Paratz, Jennifer D., Paratz, Elizabeth D., Boots, Rob J. and Jeffrey Lipman (2008). Continuous infusion of time-dependent antibiotics: lung pharmacokinetics and pharmacodynamics. Clinical Pulmonary Medicine, 15 (3), 167-172. doi: 10.1097/CPM.0b013e3181729d3d |
